<?xml version="1.0" encoding="UTF-8"?>
<p>In the present study, we employed systemic DNA immunizations against IAV with genetic adjuvants derived from innate immune pathways. In particular, we tested IPS1 and constitutively active RIG-I from the RIG-I pathway and IL-1Î² as well as IL-18 from the NALP3 inflammasome pathway.</p>
